Key result
Nalbuphine matches morphine for sedation and respiratory depression without causing cardiovascular changes.
Why the study?
Premedication for cardiac surgical patients aims to relieve anxiety with minimal cardiorespiratory changes, but comparative effects of nalbuphine and morphine were unclear.
Does nalbuphine premedication produce similar cardiorespiratory effects and anxiety relief compared to morphine in adult cardiac surgical patients?
Does nalbuphine premedication produce similar cardiorespiratory effects and anxiety relief compared to morphine in adult cardiac surgical patients?
Answers are grounded in this paper and cite their sources.
Nalbuphine provides comparable sedation, anxiety relief, and respiratory depression to morphine without cardiovascular changes in cardiac surgical patients.
Premedication for cardiac surgical patients attempts to achieve relief of anxiety with minimal or no cardiorespiratory changes. Nalbuphine (NUBAIN) and morphine produced similar decreases in respiratory rate (1-3 breaths per min) and PaO2 (averaging 1.34 kPa), and increases in arterial PaCO2 (averaging 0.56 kPa). Cardiovascular changes were not seen with either agent. A similar degree of sedation and relief of anxiety was achieved with both drugs. Side effects were minimal and infrequent. Nalbuphine produces respiratory depression and sedation without cardiovascular changes which is comparable to an equivalent dose of morphine in patients with either valvular or coronary artery disease.
No takes yet. Share an insight, caveat, or question.
Lake et al. (1984) studied Adult cardiac surgical patients with valvular or coronary artery disease. Nalbuphine vs. Morphine was evaluated on Cardiorespiratory changes, sedation, and relief of anxiety. Nalbuphine premedication produced comparable sedation and respiratory depression to morphine without cardiovascular changes.
Synapse has enriched 10 related papers. Consider them for comparative context: